, a U.S. engineering, architecture, and management services company, has signed an alliance agreement with Toyo Engineering Corp.
of Japan to develop and execute biopharmaceutical capital projects in Asia. Middough will combine its pharma and biopharma technical expertise with Toyo’s engineer-procure-construct project delivery capabilities in Asia. Middough will provide technology transfer services to Toyo staff based in Japan and China. The alliance allows both companies to serve global clients requiring pharma and biopharma expertise and engineering solutions in Asia.
“We are excited to be leveraging in-country bases of operation to serve this market with our established skills and expertise in biopharmaceuticals,” said Charles K. Dietz, general manager and senior vice president of Middough’s Life Science Business. “Toyo, Middough and our clients will all gain from this Teaming Agreement by expanding our technical and geographic reach to the rapidly developing biopharmaceutical manufacturing sector in Asia.”